Medicines

Here you will find the recommendations we have made about the use of individual medicines in Lancashire.

Ticagrelor

Brand: Brilique ®
NICE TA: 420
Indication: Prevention of atherothrombotic events after myocardial infarction in adults. (NICE TA420)
Disease category: Cardiovascular system
Commissioning responsibility: CCG
PbR excluded: No

Background

Ticagrelor, in combination with aspirin, is recommended within its marketing authorisation as an option for preventing atherothrombotic events in adults who had a myocardial infarction and who are at high risk of a further event. Treatment should be stopped when clinically indicated or at a maximum of 3 years.

Recommendation

LMMG recommendation: Amber0
Click here to find the definitions for the colour classifications

Reason for decision:  Suitable for GP prescribing following recommendation/initiation by specialist

Supporting documents:

NICE TA420 - Ticagrelor for preventing atherothrombotic events after myocardial infarction

Decisions of Lancashire local decision making groups:

NHS Blackburn With Darwen CCG and NHS East Lancashire CCG NHS Blackpool CCG NHS Chorley and South Ribble CCG and NHS Greater Preston CCG NHS Fylde and Wyre CCG NHS Morecambe Bay CCG NHS West Lancashire CCG

Amber0

Amber0

Amber0

Amber0

Amber

Amber0